{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:19:54Z","timestamp":1781896794207,"version":"3.54.5"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,18]],"date-time":"2001-12-18T00:00:00Z","timestamp":1008633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2002,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cannabis may have medicinal uses in a variety of diseases. The neural mechanisms underlying dystonia involve abnormalities within the basal ganglia\u2014in particular, overactivity of the lateral globus pallidus (GPl). Cannabinoid receptors are located presynaptically on GABA terminals within the GPi, where their activation reduces GABA reuptake. Cannabinoid receptor stimulation may thus reduce overactivity of the GPl and thereby reduce dystonia. A double\u2010blind, randomised, placebo\u2010controlled, crossover study using the synthetic cannabinoid receptor agonist nabilone in patients with generalised and segmental primary dystonia showed no significant reduction in dystonia following treatment with nabilone. \u00a9 2001 Movement Disorder Society.<\/jats:p>","DOI":"10.1002\/mds.1280","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T18:17:27Z","timestamp":1030299447000},"page":"145-149","source":"Crossref","is-referenced-by-count":91,"title":["Randomised, double\u2010blind, placebo\u2010controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia"],"prefix":"10.1002","volume":"17","author":[{"given":"Susan H.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Peter","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan R.","family":"Crossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Brotchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,1,25]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/00207458608985678"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050203"},{"key":"e_1_2_6_4_2","first-page":"71","article-title":"Advances in understanding the neural mechanisms underlying L\u2010DOPA\u2010induced dyskinesia","volume":"80","author":"Brotchie JM","year":"1999","journal-title":"Adv Neurol"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120606"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.65.5.767"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370313"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050113"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/115.3.809"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00484-M"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.5.1932"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90970-7"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90352-G"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(88)90106-4"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(88)90130-X"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(98)00374-4"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00326-3"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<382::AID-SYN9>3.0.CO;2-7"},{"key":"e_1_2_6_20_2","series-title":"Dystonia 3, advances in neurology","first-page":"1","author":"Fahn S","year":"1987"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.1.73"},{"issue":"2","key":"e_1_2_6_22_2","first-page":"1.035","article-title":"The effects of the cannabinoid receptor agonist, nabilone on L\u2010DOPA\u2010induced dyskinesia in patients with idiopathic Parkinson's disease","volume":"13","author":"Sieradzan K","year":"1998","journal-title":"Mov Disord"},{"issue":"2","key":"e_1_2_6_23_2","first-page":"2.032","article-title":"A role for cannabinoid receptor stimulation in the treatment of L\u2010DOPA\u2010induced dyskinesia in Parkinson's disease","volume":"13","author":"Fox SH","year":"1998","journal-title":"Mov Disord"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530020-00002"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1983.247"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00434401"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02618.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(79)35539-7"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt197722185"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.1280","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmds.1280","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.1280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:43:03Z","timestamp":1760964183000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.1280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["10.1002\/mds.1280"],"URL":"https:\/\/doi.org\/10.1002\/mds.1280","archive":["Portico"],"relation":{},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}